Pain Channel
Topics & Medications
Related Channels

Benefits of Darvocet

In November 2010, the United States Food and Drug Administration (FDA) withdrew all medications that contain propoxyphene from the market. It has been determined that the risks of propoxyphene outweigh the possible benefits. In particular, the FDA was concerned about the drug's ability to cause serious changes in the heart rhythm, even at normal doses. Pharmacies will no longer sell this medication, and people who take it should stop and ask their healthcare provider for a more suitable pain medication.
Darvocet® (propoxyphene/acetaminophen) is a prescription medicine licensed for relieving mild-to-moderate pain, with or without a fever. It comes in tablet form and is typically taken every four hours as needed for pain.
There are many benefits of Darvocet. One of the active ingredients in the medication (propoxyphene) is a mild, centrally acting, narcotic pain reliever. "Centrally acting" means that it works in the central nervous system (the spinal cord and brain). Propoxyphene is chemically related to methadone.
The other active ingredient in Darvocet is acetaminophen (commonly known as "APAP"). It is a pain reliever and fever reducer commonly found in non-prescription medications such as Tylenol®. Adding acetaminophen to propoxyphene increases the effectiveness for relieving pain and also provides fever-reducing effects.
(Click Darvocet for more information about Darvocet's benefits, to find out what you should discuss with your healthcare provider before using this medication, and to learn about the potential side effects of this drug.)
What Your Pharmacist Wishes You Knew About Chronic Pain Medications
Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2019 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.